39 Companies Make Active Investments in Drug Addiction Pipeline Drugs
The global demand for Drug Addiction treatment options is emerging rapidly driven by demand in major emerging and developed markets. An increasing number of companies are working on Drug Addiction pipeline. Companies quickly adapting to the new technologies both independently and through collaborations and advancing their pipeline candidates to advanced phases will evolve as top performers. However, challenges of completing clinical trials on schedules and limited financial support are holding some of the Drug Addiction pipeline companies from advancing their products into Phase 3 or Phase 4.
Drug Addiction Report Description- The 2019 pipeline study on Drug Addiction pipeline is a comprehensive research on the drug candidates across different phases. This research study evaluates each of the pipeline products in terms of their current status, regulatory progress and expected phase completion date. Focusing on the factors driving and challenging pipeline drug development, this strategic analysis review presents detailed analysis on all active Drug Addiction pipeline compounds.
The Drug Addiction pipeline guide presents information on all active drugs currently being developed for Drug Addiction. The research work provides details of active therapeutic candidates in different phases including discovery, research, pre-clinical, phase I, Phase II, Phase III and pre-registration phases.
Details of current status, R&D progress and latest developments for every Drug Addiction pipeline candidate are analyzed.
Further, current phase of development, mechanism of drug action, special designations such as orphan drug status, fast track designation, grants awarded, etc are presented for all Drug Addiction drug candidates.
Drug development companies, collaborators, originating companies, license providers and universities participating in the Drug Addiction product pipeline are provided. Company overview, snapshot and developments are provided for all participating companies.
The report assists in identifying potential upcoming companies and drugs in Drug Addiction pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
VPA Research has developed a robust methodology for assessing pharmaceutical drugs, market sizes and sound forecast tools. All our research reports are provided through intense and repetitive primary and secondary research methods. Further, these reports are validated with industry experts to ensure reliability in the current scenario. The report is presented in a user-friendly format and presents clear and actionable insights.
Scope of Drug Addiction pipeline report includes- - An overview of Drug Addiction disease including symptoms, causes, diagnosis and available treatment options is provided.
- Snapshot of pipeline detailing number of active compounds, mergers and acquisitions, phase wise compounds, target areas, mechanism of action, trials etc
- Phase wise count of Drug Addiction pipeline
- Company wise list of Drug Addiction pipeline
- Mechanism of Action wise Drug Addiction pipeline
- For each pipeline candidate, the following details are provided- • Snapshot (Drug, Mechanism of Action, Phase, Co Developer, Originator, Synonym, Orphan Drug Status, New Molecular Entity, Area) • Current status of development • Drug overview • Mechanism of Action • Pre-clinical and Clinical Trials/Results
- Company Overview and Recent Developments
Reasons to Buy- - The report is designed to help industry executives promote the success and continued growth of their organizations
- Get clear understanding of the entire Drug Addiction pipeline, with details on active projects
- Stay ahead of the competition through comprehensive knowledge of Drug Addiction pipeline progress
- Get in detail information of each product with updated information on each project along with key milestones
- Gain clear insights into companies participating in Drug Addiction pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data
- Get trial information for each pipeline product under development
- Understand the pipeline structure in terms of mechanism of Action, phase and company
The report will be delivered in 2 working days.
Our reports have been used by over 10K customers, including:
Biopreservation refers to the process of preserving cells, tissues or organs outside of their native environment for extended period of time. It has emerged as an effective preservation technique for long-term storage. Owing to this, biopreservation has become vital for the success of various clinical and commercial...
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028 Healthcare CRO Market Growth & Trends The global healthcare...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to decline from $0.80 billion in 2019 to $0.77...
This report analyzes the regulatory framework for the clinical trials of orphan drugs in rare and orphan diseases.The report also analyzes the trends and characteristics of clinical trials conducted on rare diseases from 1999-2018, using information from various sources.
This report covers an overview...
Drug Discovery Market Report Overview Drug Discovery market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Drug Discovery market types and applications. It is a focused study on Drug Discovery market space including global and regional eight-year...
120 pages •
By Infiniti Research Limited
• Dec 2020
Global Microarray Biochips Market 2020-2024
The analyst has been monitoring the microarray biochips market and it is poised to grow by $ 10.22 bn during 2020-2024 progressing at a CAGR of 20% during the forecast period. Our report on microarray biochips market provides a holistic analysis, market size and forecast, trends,...
120 pages •
By Infiniti Research Limited
• Dec 2020
Global Gel Electrophoresis Market 2020-2024
The analyst has been monitoring the gel electrophoresis market and it is poised to grow by $ 381.92 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. Our report on gel electrophoresis market provides a holistic analysis, market size and forecast, trends,...
The comprehensive 2,400 page research study on COVID-19 therapeutic and vaccine pipeline candidates, completed, ongoing and planned clinical trials across phases, countries, companies and institutes/hospitals. The global COVID-19 market size outlook remains robust driven by huge potential for administration to 2 billion populations,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.